X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/pharma/eli-lillys-growth-drivers-verzenio-and-jardiance-suffer-clinical-setbacks-0
https://www.pharmaceutical-technology.com/news/eli-lilly-q1-net-income/
https://www.fiercepharma.com/pharma/eli-lillys-verzenio-fails-prostate-cancer-test-possible-novartis-showdown-nears
https://www.prnewswire.com/news-releases/lilly-to-present-final-overall-survival-analysis-from-the-monarch-3-study-of-verzenio-abemaciclib-and-additional-results-from-its-breast-cancer-portfolio-at-the-2023-san-antonio-breast-cancer-symposium-302005301.html
https://www.globenewswire.com//news-release/2023/11/28/2786889/0/en/eFFECTOR-Receives-U-S-FDA-Fast-Track-Designation-for-Zotatifin-in-Combination-with-Fulvestrant-and-Abemaciclib-for-Treatment-of-ER-HER2-Advanced-Metastatic-Breast-Cancer.html
https://www.prnewswire.com/news-releases/landmark-5-year-monarche-outcome-data-demonstrate-verzenio-abemaciclibs-long-term-impact-on-cancer-recurrence-in-high-risk-early-breast-cancer-301962737.html
https://www.prnewswire.com/news-releases/lilly-highlights-verzenio-abemaciclib-and-jaypirca-pirtobrutinib-data-at-2023-asco-annual-meeting-301840771.html
https://www.clinicaltrialsarena.com/news/effector-updates-cancer-combo-expansion/
https://www.prnewswire.com/news-releases/us-fda-broadens-indication-for-verzenio-abemaciclib-in-hr-her2--node-positive-high-risk-early-breast-cancer-301762459.html
https://www.fiercepharma.com/pharma/eli-lilly-aims-verzenio-broader-postsurgery-breast-cancer-nod-novartis-draws-near-will-fda
https://www.prnewswire.com/news-releases/lilly-announces-updated-data-from-the-verzenio-abemaciclib-phase-3-monarche-trial-presented-at-sabcs-and-simultaneously-published-in-the-lancet-oncology-301696229.html
https://www.fiercepharma.com/pharma/eli-lilly-aims-verzenio-broader-postsurgery-breast-cancer-nod-novartis-draws-near-will-fda
https://www.fiercepharma.com/marketing/eli-lillys-verzenio-further-pressures-pfizer-nice-backing-postsurgery-breast-cancer
https://www.pharmatimes.com/news/nice_recommends_eli_lillys_breast_cancer_therapy_1450121
https://www.pharmatimes.com/news/mhra_marketing_authorisation_granted_for_eli_lillys_verzenios_as_early_breast_cancer_treatment_1448503
https://www.globenewswire.com/news-release/2022/02/01/2376723/11676/en/Veru-Enters-into-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Eli-Lilly-and-Company-to-Evaluate-Enobosarm-in-Combination-with-Verzenio-in-Phase-3-ENABLAR-2-Trial.html
https://www.prnewswire.com/news-releases/additional-verzenio-abemaciclib-phase-3-monarche-trial-data-published-in-the-annals-of-oncology-301411243.html
https://www.prnewswire.com/news-releases/lilly-announces-updated-verzenio-abemaciclib-phase-3-monarche-trial-data-presented-at-esmo-virtual-plenary-and-simultaneously-published-in-the-annals-of-oncology-301400654.html
https://www.evaluate.com/vantage/articles/news/snippets/lilly-wins-breast-cancer-adjuvant-race
https://www.prnewswire.com/news-releases/new-data-from-verzenio-abemaciclib-monarche-study-to-be-featured-in-esmo-virtual-plenary-301384959.html
http://www.pmlive.com/pharma_news/nice_approval_for_lillys_verzenios_is_fantastic_news_for_thousands_of_women_1374876
http://www.pmlive.com/pharma_news/nice_approval_for_lillys_verzenios_is_fantastic_news_for_thousands_of_women_1374876
http://www.pmlive.com/pharma_news/nice_approval_for_lillys_verzenios_is_fantastic_news_for_thousands_of_women_1374876
https://www.theguardian.com/society/2021/aug/12/breast-cancer-drug-approved-for-nhs-after-maker-agrees-discount
https://www.fiercepharma.com/manufacturing/end-to-end-how-pharma-making-dream-continuous-manufacturing-a-reality
https://www.fiercepharma.com/pharma/look-for-eli-lilly-s-verzenio-to-reach-4b-after-early-breast-cancer-win-analyst
http://www.pharmatimes.com/news/nice_rejects_lillys_verzenios_for_advanced_breast_cancer_1363315
https://www.pharmaceutical-journal.com/news-and-analysis/news/addition-of-abemaciclib-to-hormonal-therapy-for-high-risk-early-breast-cancer-reduces-recurrence-by-25-research-suggests/20208376.article?firstPass=false#:~:text=Combining%20abemaciclib%20with%20hormonal%20therapy,2020%20European%20Society%20for%20Medical
https://www.fiercepharma.com/marketing/esmo-lilly-s-verzenio-pressures-pfizer-practice-changing-win-early-breast-cancer
https://www.esmo.org/meetings/esmo-virtual-congress-2020/meeting-resources/scientific-news/abemaciclib-improves-os-in-combination-with-tamoxifen-in-hr-positive-her2-negative-metastatic-breast-cancer
https://www.foxnews.com/health/drug-therapy-breast-cancer-lilly
https://www.prnewswire.com/news-releases/verzenio-significantly-reduced-the-risk-of-cancer-recurrence-by-25-for-people-with-hr-her2--high-risk-early-breast-cancer-301134339.html
https://www.globenewswire.com/news-release/2020/07/27/2067774/0/en/Zentalis-Pharmaceuticals-Enters-into-Clinical-Collaboration-with-Eli-Lilly-and-Company-to-Evaluate-its-Oral-SERD-ZN-c5-in-Combination-with-Abemaciclib-a-CDK4-and-6-Inhibitor.html
https://www.globenewswire.com/news-release/2020/07/08/2059504/0/en/ViralClear-Pharmaceuticals-partners-with-Albany-Molecular-Research-Inc-on-the-manufacture-of-merimepodib-active-pharmaceutical-ingredient-development-for-the-potential-treatment-of.html
https://www.fiercepharma.com/marketing/lilly-s-verzenio-hits-goal-for-early-breast-cancer-use-where-pfizer-s-ibrance-faltered
https://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-studies-the-use-of-cyclin-dependent-kinase-46-inhibitors-in-breast-cancer-patients-301056092.html
https://www.raps.org/news-and-articles/news-articles/2019/11/fdas-project-orbis-may-expand-to-singapore-and-sw
https://endpts.com/novartis-eli-lilly-marquee-positive-survival-data-for-cdk-4-6-franchises-but-can-they-actually-beat-pfizers-blockbuster/
https://www.raps.org/news-and-articles/news-articles/2019/9/fda-collaborates-with-health-canada-australia-to
https://endpts.com/fda-collaborates-with-health-canada-australia-to-approve-new-cancer-drugs/
https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/fda-warns-of-possible-interstitial-lung-disease-pneumonitis-with-certain-breast-cancer-drugs/
https://www.raps.org/news-and-articles/news-articles/2019/9/three-breast-cancer-drugs-fda-warns-of-rare-but-s
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-severe-lung-inflammation-ibrance-kisqali-and-verzenio-breast-cancer
http://www.pmlive.com/pharma_news/lilly_boosted_by_survival_data_for_key_growth_drug_verzenio_1296047
http://www.pharmatimes.com/news/eli_lilly_announces_verzenio_survival_benefit_1295959
http://www.pharmafile.com/news/525445/lillys-verzenio-combo-shows-additional-breast-cancer-survival-benefit-new-phase-3-data
Market Place
Share 
